Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)
Authors:
- Sheila M. HegdeSHSheila M. Hegde
- Brian ClaggettBCBrian Claggett
- Amil M. ShahASAmil M. Shah
- Eldrin F. LewisELEldrin F. Lewis
- Inder AnandIAInder Anand
- Sanjiv J. ShahSSSanjiv J. Shah
- Nancy K. SweitzerNSNancy K. Sweitzer
- James C. FangJFJames C. Fang
- Bertram PittBPBertram Pitt
- Marc A. PfefferMPMarc A. Pfeffer
- Scott D. SolomonSSScott D. Solomon
- 12 September 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 136 (11) , 982-992
Abstract
Background: Physical activity (PA) is inversely associated with adverse cardiovascular outcomes in healthy populations, but the impact of physical activity in patients with heart failure (HF) with preserved ejection fraction is less well characterized. Methods: The baseline self-reported PA of 1751 subjects enrolled in the Americas region of the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) was categorized as poor, intermediate, or ideal PA with American Heart Association criteria. PA was related to the primary composite outcome (HF hospitalization, cardiovascular mortality, or aborted cardiac arrest), its components, and all-cause mortality with the use of multivariable Cox models. Results: The mean age at enrollment was 68.6±9.6 years. Few patients met American Heart Association criteria for ideal activity (11% ideal, 14% intermediate, 75% poor). Over a median follow-up of 2.4 years, the primary composite outcome occurred in 519 patients (397 HF hospitalizations, 222 cardiovascular deaths, and 6 aborted cardiac arrests). Compared with those with ideal baseline PA, poor and intermediate baseline PA was associated with a greater risk of the primary outcome (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.28–3.28; HR, 1.95; 95% CI, 1.15–3.33, respectively), HF hospitalization (HR, 1.93; 95% CI, 1.16–3.22; HR, 1.84; 95% CI, 1.02–3.31), cardiovascular mortality (HR, 4.36; 95% CI, 1.37–13.83; HR, 4.05; 95% CI, 1.17–14.04), and all-cause mortality (HR, 2.95; 95% CI, 1.44–6.02; HR, 2.05; 95% CI, 0.90–4.67) after multivariable adjustment for potential confounders. Conclusions: In patients with HF with preserved ejection fraction, both poor and intermediate self-reported PA were associated with higher risk of HF hospitalization and mortality. Clinical Trial Registration: URL: https://clinicaltrials.gov . Unique identifier: NCT00094302.Keywords
This publication has 48 references indexed in Scilit:
- Dose–Response Relationship Between Physical Activity and Risk of Heart FailureCirculation, 2015
- Leisure-Time Running Reduces All-Cause and Cardiovascular Mortality RiskJACC, 2014
- 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular RiskCirculation, 2014
- Effect of Endurance Exercise Training on Endothelial Function and Arterial Stiffness in Older Patients With Heart Failure and Preserved Ejection FractionJACC, 2013
- Physical Activity and Cardiovascular Disease in African Americans in Atherosclerosis Risk in CommunitiesMedicine & Science in Sports & Exercise, 2013
- Cardiovascular effects of 1 year of progressive endurance exercise training in patients with heart failure with preserved ejection fractionAmerican Heart Journal, 2012
- Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection FractionJACC, 2011
- Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort studyThe Lancet, 2011
- Exercise Training in Older Patients With Heart Failure and Preserved Ejection FractionCirculation: Heart Failure, 2010
- A Prospective Study of Walking as Compared with Vigorous Exercise in the Prevention of Coronary Heart Disease in WomenNew England Journal of Medicine, 1999